Live Geos: https://partners.subjectwell.com/publishers/geos_report/fc86508a-cc02-46da-ae12-ca5dd56698fe **ALL COPY AND CREATIVE MUST BE SUBMITTED TO [email protected] PRIOR TO SETTING LIVE FOR COMPLIANCE** Ages: 18-80 Gender: Any Study Description: This study is testing an investigational injectable medication compared to a placebo for the treatment of moderate to severe asthma. Participants will receive the study medication or placebo for approximately 11 months. Additional procedures include physical examinations, laboratory tests and e-diary completion. Total participation will last approximately 1 year and 1 month with 16 doctor’s visits throughout the study. Eligibility for the study will be determined by the study doctor following one in-person screening visits to the clinic. Trial-related procedures and study medication will be provided at no cost. Qualifications: - Must be diagnosed with asthma 1 year or longer Highest DQs: - Must be taking a daily inhaled corticosteroid (ICS) with or without other asthma meds for at least 3 months - In the past year, had to have had two or more asthma exacerbations that required treatment with corticosteroids that led to an emergency room/urgent care visit/hospitalization

ClicksAdv, LLC